Robert M Cash, MD
Orthopedic Surgery · Modesto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
- Since medical school
- 35 years
- University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb), 1991
Offices
3 locations · Orion Orthopaedic Trauma Inc · County of San Joaquin · Samaritan Pacific Health Services Inc
Hospitals listed: Good Samaritan Regional Medical Center · Samaritan North Lincoln Hospital · Samaritan Pacific Community Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cash’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G82064 · Current
Licensed to practise in California · since 1995 · expires 2027-06-30 · University of Illinois College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Valley Surgery Center at ModestoAmbulatory Surgery Center · Modesto, CA6.15% owner since 2018 · accredited by HFAPInitial Accreditation1 inspection, 1 with deficiencies · last 2023-08-01
- Valley Surgery Center, L.P.Ambulatory Surgery Center · Modesto, CAOwner · accredited by JCAccreditation Renewed2 inspections, 2 with deficiencies · last 2011-06-06: Requirements Met
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan Regional Medical CenterCorvallis, ORAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Samaritan Health Services, which runs 5 hospitalsPatients rate it 4 of 5 · 71% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.347, Oct 2024 – Sep 2025
- Samaritan North Lincoln HospitalLincoln City, ORCritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Samaritan Health Services, which runs 5 hospitalsPatients rate it 4 of 5 · 75% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Samaritan Pacific Community HospitalNewport, ORCritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Samaritan Health Services, which runs 5 hospitalsPatients rate it 4 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Good Samaritan Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.347 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 720 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.77 (0.44 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 164.59 (106.7 to 222.49) · 42 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.3 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.5 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14.7 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.9 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 189 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 2,428 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.06 to 0.48) · 3,639 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.48) · 3,734 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.56 (1.45 to 5.67) · 1,350 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 728 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.9 to 3.82) · 1,313 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.16 (1.83 to 14.48) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.47 (0 to 7) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 197 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,885 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 65 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.226 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.418 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.919 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 319 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.7 · 423 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 14.5 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.3 · 271 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.5 · 153 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 266 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (4 to 9) · 100 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.4 (6.6 to 13.3) · 100 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.9 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 98 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.7) · 249 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 583 cases | No different | Jan 2024 – Dec 2024 |
What patients said (806 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 55% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Samaritan North Lincoln Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 0 better, 6 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 8.9 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.4 · 57 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 27 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 293 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 67 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8 · 60 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -27.1 · 49 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 60 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (3.8 to 9.2) · 59 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.8 (6.6 to 14.2) · 59 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 44 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 35 cases | No different | Jan 2022 – Dec 2024 |
What patients said (167 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 86% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 80% |
| Doctors "always" listened carefully | 83% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 83% |
| Nurses "always" explained things so they could understand | 86% |
| Nurses "always" listened carefully | 83% |
| Nurses "always" treated them with courtesy and respect | 90% |
| "Always" quiet at night | 66% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 56% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Samaritan Pacific Community Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 1 worse of 5 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 13.6 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.6 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 35 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 375 cases | None | Jul 2024 – Jun 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.8 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 74.2 · 113 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 4.8 · 62 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.3 (4 to 9.5) · 63 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.7 to 16) · 63 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.3 to 16.6) · 364 cases | No different | Jan 2022 – Dec 2024 |
What patients said (214 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 3 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 81% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 82% |
| Nurses "always" listened carefully | 83% |
| Nurses "always" treated them with courtesy and respect | 90% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 55% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
Original Medicare doctor bills
$145,654
Medicare paid this office $145,654 for 258 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 122 | $21,903 | $93 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 48 | $20,572 | None |
| Replacement of knee joint, both sides of knee | 19 | $19,918 | $996 |
| Short return visit (20+ min) | 151 | $16,550 | $64 |
| Replacement of thigh bone and hip joint with prosthesis | 12 | $13,074 | $1,006 |
See all 13 services
| Return visit (30+ min) | 122 | $21,903 | $93 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 48 | $20,572 | None |
| Replacement of knee joint, both sides of knee | 19 | $19,918 | $996 |
| Short return visit (20+ min) | 151 | $16,550 | $64 |
| Replacement of thigh bone and hip joint with prosthesis | 12 | $13,074 | $1,006 |
| Aspiration and/or injection of fluid from large joint | 91 | $6,471 | $48 |
| New patient visit (30+ min) | 48 | $3,778 | $79 |
| New patient visit (45+ min) | 29 | $3,050 | $105 |
| X-ray of knee, 3 views | 65 | $3,041 | $31 |
| X-ray of hip, 2-3 views | 19 | $963 | $39 |
| X-ray of shoulder, minimum of 2 views | 27 | $813 | $26 |
| Injection, methylprednisolone acetate, 1 mg | 45 | $216 | None |
| Injection, methylprednisolone acetate, 40 mg | 12 | $40 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 188 | 243 | 236 | 214 | 138 | 135 |
| Replacement of knee joint, both sides of knee | 22 | 20 | 25 | 19 | 23 | 20 |
| Replacement of thigh bone and hip joint with prosthesis | 12 | – | – | – | – | 13 |
| Repair of shoulder rotator cuff using an endoscope | 13 | 11 | – | – | – | – |
| Removal of extensive shoulder joint tissue using an endoscope | 12 | – | 11 | – | – | – |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 11 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
258 Original Medicare patients in 2024. Average age 73 · Under 65 7% · 85 and older 5% · Women 61% · Also on Medicaid 13% · Health risk score 1.16. Above the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 40% · Coronary heart disease 24% · Chronic kidney disease 20% · Depression 19% · Atrial fibrillation 17% · Cancer 13% · Heart failure 12% · COPD 12% · Dementia 6% · Stroke 6%.
The office billed $359,798, Medicare allowed $191,438 and paid $145,654; for 7,185 services of 59 kinds; $21,589 of it was for drugs given in the office and $124,064 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 258 | 7,185 | 73 | 1.16 | $359,798 | $145,654 |
| 2023 | 287 | 4,896 | 73 | 1.20 | $365,369 | $153,637 |
| 2022 | 278 | 1,982 | 72 | 1.11 | $451,107 | $171,568 |
| 2021 | 331 | 1,761 | 73 | 1.12 | $532,687 | $199,695 |
| 2020 | 295 | 1,404 | 72 | 1.18 | $461,601 | $163,487 |
| 2019 | 372 | 1,486 | 73 | 1.33 | $530,609 | $190,758 |
| 2018 | 378 | 1,455 | 72 | 1.32 | $464,824 | $129,730 |
| 2017 | 387 | 2,658 | 70 | 1.30 | $767,055 | $187,756 |
| 2016 | 381 | 2,565 | 71 | 1.34 | $605,857 | $160,035 |
| 2015 | 421 | 3,074 | 71 | 1.30 | $700,744 | $180,976 |
| 2014 | 432 | 2,786 | 70 | 1.05 | $760,485 | $209,089 |
| 2013 | 399 | 3,362 | 71 | 1.29 | $699,666 | $202,304 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Replacement of knee joint, both sides of knee | 22 | $22,688 | $986 |
| Return visit (30+ min) | 120 | $20,539 | $97 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 42 | $18,825 | None |
| Short return visit (20+ min) | 145 | $15,389 | $63 |
| New patient visit (45+ min) | 64 | $7,821 | $122 |
| Aspiration and/or injection of fluid from large joint | 79 | $6,543 | $47 |
| New patient visit (30+ min) | 64 | $5,172 | $81 |
| X-ray of knee, 3 views | 61 | $2,819 | $31 |
| X-ray of hip, 2-3 views | 19 | $836 | $38 |
| X-ray of shoulder, minimum of 2 views | 24 | $761 | $27 |
| Injection, methylprednisolone acetate, 40 mg | 45 | $327 | None |
2022: 11 services
| Return visit (30+ min) | 147 | $29,335 | $96 |
| Short return visit (20+ min) | 136 | $19,170 | $68 |
| Replacement of knee joint, both sides of knee | 19 | $18,867 | $993 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 31 | $14,212 | None |
| Aspiration and/or injection of fluid from large joint | 71 | $10,650 | $50 |
| New patient visit (45+ min) | 55 | $6,909 | $126 |
| New patient visit (30+ min) | 49 | $3,780 | $77 |
| X-ray of knee, 3 views | 59 | $3,038 | $35 |
| X-ray of hip, 2-3 views | 24 | $1,247 | $40 |
| X-ray of shoulder, minimum of 2 views | 25 | $973 | $29 |
| Injection, methylprednisolone acetate, 40 mg | 49 | $354 | None |
2021: 15 services
| Replacement of knee joint, both sides of knee | 23 | $26,370 | $1,055 |
| Return visit (30+ min) | 134 | $25,532 | $101 |
| Short return visit (20+ min) | 141 | $19,909 | $71 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 27 | $13,147 | None |
| Aspiration and/or injection of fluid from large joint | 93 | $12,129 | $51 |
| New patient visit (30+ min) | 87 | $7,801 | $90 |
| New patient visit (45+ min) | 58 | $7,248 | $125 |
| X-ray of knee, 3 views | 52 | $2,343 | $33 |
| Removal of extensive shoulder joint tissue using an endoscope | 11 | $1,396 | $127 |
| Short return visit | 23 | $914 | $30 |
| X-ray of shoulder, minimum of 2 views | 21 | $825 | $28 |
| X-ray of hip, 2-3 views | 17 | $800 | $40 |
| X-ray of wrist, minimum of 3 views | 11 | $465 | $31 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 53 | $415 | None |
| Injection, methylprednisolone acetate, 40 mg | 34 | $173 | None |
2020: 11 services
| Replacement of knee joint, both sides of knee | 20 | $22,420 | $1,121 |
| Short return visit (20+ min) | 191 | $22,027 | $56 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 39 | $16,572 | None |
| Aspiration and/or injection of fluid from large joint | 91 | $11,816 | $49 |
| Repair of shoulder rotator cuff using an endoscope | 11 | $8,973 | $816 |
| New patient visit (30+ min) | 117 | $8,743 | $75 |
| Return visit (30+ min) | 34 | $3,518 | $84 |
| X-ray of knee, 3 views | 49 | $1,901 | $30 |
| X-ray of hip, 2-3 views | 25 | $1,087 | $34 |
| X-ray of shoulder, minimum of 2 views | 16 | $534 | $27 |
| Injection, methylprednisolone acetate, 40 mg | 72 | $446 | None |
2019: 17 services
| Replacement of knee joint, both sides of knee | 22 | $23,366 | $1,062 |
| Short return visit (20+ min) | 202 | $20,334 | $54 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 21 | $17,824 | None |
| Replacement of thigh bone and hip joint with prosthesis | 12 | $13,167 | $1,097 |
| Repair of shoulder rotator cuff using an endoscope | 12 | $11,202 | $862 |
| New patient visit (30+ min) | 149 | $10,458 | $70 |
| Aspiration and/or injection of fluid from large joint | 83 | $7,961 | $42 |
| Return visit (30+ min) | 59 | $5,572 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,009 | $155 |
| X-ray of knee, 3 views | 49 | $1,777 | $28 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 11 | $1,551 | $141 |
| Removal of extensive shoulder joint tissue using an endoscope | 11 | $1,466 | $122 |
| X-ray of hip, 2-3 views | 24 | $939 | $32 |
| Short return visit | 12 | $764 | $31 |
| X-ray of shoulder, minimum of 2 views | 16 | $606 | $25 |
| X-ray of knee, 1-2 views | 17 | $410 | $23 |
| Injection, methylprednisolone acetate, 40 mg | 72 | $393 | None |
2018: 17 services
| Short return visit (20+ min) | 247 | $21,664 | $50 |
| Replacement of thigh bone and hip joint with prosthesis | 13 | $13,310 | $951 |
| Replacement of knee joint, both sides of knee | 13 | $12,692 | $976 |
| New patient visit (30+ min) | 146 | $11,327 | $78 |
| Removal of knee cartilage using an endoscope | 11 | $3,950 | $359 |
| Aspiration and/or injection of fluid from large joint | 64 | $3,574 | $41 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 47 | $1,835 | $39 |
| Return visit (30+ min) | 18 | $1,512 | $80 |
| X-ray of knee, 3 views | 27 | $820 | $28 |
| X-ray of hip, 2-3 views | 16 | $589 | $33 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 41 | $513 | None |
| X-ray of knee, 1-2 views | 16 | $491 | $23 |
| Short return visit | 13 | $407 | $27 |
| X-ray of shoulder, minimum of 2 views | 14 | $393 | $23 |
| Injection, methylprednisolone acetate, 40 mg | 25 | $168 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 40 | $16 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 35 | $1 | None |
2017: 15 services
| Replacement of knee joint, both sides of knee | 27 | $29,474 | $1,053 |
| Short return visit (20+ min) | 262 | $26,018 | $51 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 12 | $11,221 | $935 |
| Treatment of broken neck of thigh bone with bone implant | 12 | $11,106 | $925 |
| Repair of shoulder rotator cuff using an endoscope | 13 | $10,786 | $830 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 14 | $7,795 | None |
| New patient visit (30+ min) | 95 | $7,173 | $76 |
| Aspiration and/or injection of fluid from large joint | 76 | $4,723 | $41 |
| Removal of extensive shoulder joint tissue using an endoscope | 18 | $3,364 | $187 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 73 | $3,350 | $40 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 14 | $1,915 | $137 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 76 | $938 | None |
| Short return visit | 20 | $878 | $29 |
| Injection, dexamethasone sodium phosphate, 1 mg | 74 | $33 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 67 | $2 | None |
2016: 11 services
| Replacement of knee joint, both sides of knee | 29 | $31,917 | $1,064 |
| Short return visit (20+ min) | 284 | $28,010 | $51 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 15 | $9,538 | None |
| New patient visit (30+ min) | 105 | $7,489 | $71 |
| Aspiration and/or injection of fluid from large joint | 72 | $4,618 | $44 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,548 | $150 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 57 | $2,457 | $42 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 67 | $747 | None |
| Training in the use of orthopedic device for arm, leg and/or trunk, each 15 minutes | 13 | $394 | $30 |
| Short return visit | 11 | $310 | $28 |
| Injection, dexamethasone sodium phosphate, 1 mg | 64 | $35 | None |
2015: 14 services
| Short return visit (20+ min) | 299 | $30,441 | $52 |
| Replacement of knee joint, both sides of knee | 16 | $16,370 | $1,023 |
| Treatment of broken neck of thigh bone with bone implant | 13 | $13,770 | $984 |
| Replacement of thigh bone and hip joint with prosthesis | 11 | $12,648 | $1,054 |
| New patient visit (30+ min) | 141 | $10,940 | $78 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 17 | $10,573 | None |
| Aspiration and/or injection of fluid from large joint | 92 | $6,603 | $43 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,106 | $161 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 93 | $3,989 | $39 |
| Removal of extensive shoulder joint tissue using an endoscope | 16 | $3,394 | $200 |
| Return visit (30+ min) | 16 | $1,295 | $76 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 81 | $1,025 | None |
| Training in the use of orthopedic device for arm, leg and/or trunk, each 15 minutes | 19 | $585 | $29 |
| Injection, dexamethasone sodium phosphate, 1 mg | 80 | $52 | None |
2014: 14 services
| Short return visit (20+ min) | 285 | $29,414 | $55 |
| Replacement of knee joint, both sides of knee | 18 | $21,972 | $1,099 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 17 | $10,758 | None |
| New patient visit (30+ min) | 136 | $10,617 | $78 |
| Repair of shoulder rotator cuff using an endoscope | 11 | $9,461 | $860 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $6,865 | $163 |
| Removal of extensive shoulder joint tissue using an endoscope | 23 | $5,057 | $211 |
| Aspiration and/or injection of fluid from large joint | 74 | $4,925 | $45 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 57 | $2,536 | $42 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 12 | $1,703 | $142 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,218 | $111 |
| Training in the use of orthopedic device for arm, leg and/or trunk, each 15 minutes | 34 | $1,047 | $31 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 65 | $688 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 56 | $30 | None |
2013: 14 services
| Short return visit (20+ min) | 271 | $29,471 | $53 |
| Replacement of knee joint, both sides of knee | 22 | $29,418 | $1,226 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 26 | $16,313 | None |
| Treatment of broken neck of thigh bone with bone implant | 15 | $14,702 | $980 |
| New patient visit (30+ min) | 127 | $10,377 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $6,752 | $153 |
| Aspiration and/or injection of fluid from large joint | 74 | $6,021 | $46 |
| Removal of extensive shoulder joint tissue using an endoscope | 18 | $3,797 | $211 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,474 | $108 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 45 | $2,097 | $43 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 14 | $1,938 | $138 |
| Training in the use of orthopedic device for arm, leg and/or trunk, each 15 minutes | 37 | $1,220 | $30 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 59 | $667 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 56 | $24 | None |
Medicaid work
$679 in 2024
Medicaid paid $679 for 13 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $679 |
| 2024 | 13 | 1 | 12 | $679 |
| 2023 | 68 | 2 | 16 | $2,815 |
| 2019 | 134 | 3 | 28 | $3,574 |
| 2018 | 289 | 3 | 34 | $8,036 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 56 | $2,610 |
| Short return visit (20+ min) | 12 | $205 |
2019
| OFF/OP EST MAY X REQ PHY/QHP | 109 | $2,725 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 13 | $556 |
| Short return visit | 12 | $293 |
2018
| OFF/OP EST MAY X REQ PHY/QHP | 199 | $4,975 |
| Short return visit (20+ min) | 65 | $2,389 |
| Short return visit | 25 | $672 |
Drugs they prescribed that Part D paid
$4,810
Pharmacies billed $4,810 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 65% of their Part D prescriptions (284 of 440) in 2024. A higher opioid share than 9 in 10 peers; the typical orthopedic surgery clinician is at 31%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
437 generic and fewer than 11 brand-name prescriptions · $4,810 in drug cost · 41 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 99 | $1,277 | $7 |
| Diclofenac | 22 | $736 | $19 |
| Oxycodone-Acetaminophen | 26 | $626 | $13 |
| Ibuprofen | 19 | $527 | $16 |
| Ondansetron Odt | 15 | $222 | $15 |
See all 8 drugs
| Hydrocodone-Acetaminophen | 99 | $1,277 | $7 |
| Diclofenac | 22 | $736 | $19 |
| Oxycodone-Acetaminophen | 26 | $626 | $13 |
| Ibuprofen | 19 | $527 | $16 |
| Ondansetron Odt | 15 | $222 | $15 |
| Tramadol | 23 | $191 | $4 |
| Acetaminophen-Codeine | 11 | $182 | $10 |
| Amoxicillin | 14 | $74 | $4 |
Year by year
| 2024 | 440 | 173 | 65% (284) | None | $4,810 |
| 2023 | 394 | 171 | 62% (246) | None | $7,035 |
| 2022 | 374 | 165 | 61% (227) | 0% | $6,614 |
| 2021 | 331 | 155 | 58% (192) | None | $5,163 |
| 2020 | 241 | 124 | 54% (129) | None | $3,812 |
| 2019 | 205 | 111 | 62% (127) | None | $4,033 |
| 2018 | 261 | 125 | 58% (151) | 13% | $15,567 |
| 2017 | 311 | 136 | 59% (184) | 9% | $11,943 |
| 2016 | 338 | 152 | 69% (234) | None | $12,890 |
| 2015 | 425 | 168 | 53% (224) | 11% | $22,804 |
| 2014 | 580 | 182 | 61% (356) | 12% | $22,398 |
| 2013 | 616 | 184 | 69% (425) | 10% | $23,847 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Hydrocodone-Acetaminophen | 140 | $1,487 | $11 |
| Oxycodone-Acetaminophen | 55 | $1,101 | $20 |
| Diclofenac | 30 | $895 | $30 |
| Doxycycline Monohydrate | 16 | $514 | $32 |
| Ondansetron Odt | 11 | $282 | $26 |
| Ibuprofen | 16 | $251 | $16 |
| Meloxicam | 11 | $192 | $17 |
| Tramadol | 25 | $168 | $7 |
| Acetaminophen-Codeine | 23 | $120 | $5 |
| Amoxicillin | 16 | $62 | $4 |
2022: 6 drugs
| Hydrocodone-Acetaminophen | 150 | $1,627 | $11 |
| Diclofenac | 54 | $1,586 | $29 |
| Oxycodone-Acetaminophen | 40 | $994 | $25 |
| Tramadol | 28 | $195 | $7 |
| Ibuprofen | 14 | $121 | $9 |
| Amoxicillin | 22 | $83 | $4 |
2021: 8 drugs
| Hydrocodone-Acetaminophen | 128 | $1,308 | $10 |
| Diclofenac | 31 | $1,131 | $36 |
| Oxycodone-Acetaminophen | 36 | $559 | $16 |
| Cephalexin | 12 | $350 | $29 |
| Ondansetron | 15 | $195 | $13 |
| Ibuprofen | 12 | $130 | $11 |
| Tramadol | 26 | $130 | $5 |
| Amoxicillin | 17 | $46 | $3 |
2020: 8 drugs
| Hydrocodone-Acetaminophen | 85 | $844 | $10 |
| Diclofenac | 17 | $666 | $39 |
| Oxycodone-Acetaminophen | 24 | $292 | $12 |
| Cephalexin | 11 | $167 | $15 |
| Ibuprofen | 12 | $121 | $10 |
| Meloxicam | 16 | $78 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $68 | $6 |
| Tramadol | 14 | $41 | $3 |
2019: 4 drugs
| Hydrocodone-Acetaminophen | 72 | $809 | $11 |
| Oxycodone-Acetaminophen | 27 | $431 | $16 |
| Diclofenac | 11 | $364 | $33 |
| Tramadol | 23 | $108 | $5 |
2018: 5 drugs
| Voltaren | 28 | $2,828 | $101 |
| Hydrocodone-Acetaminophen | 83 | $1,780 | $21 |
| Oxycodone-Acetaminophen | 28 | $805 | $29 |
| Tramadol | 33 | $191 | $6 |
| Meloxicam | 15 | $94 | $6 |
2017: 6 drugs
| Hydrocodone-Acetaminophen | 113 | $2,236 | $20 |
| Voltaren | 17 | $1,912 | $112 |
| Oxycodone-Acetaminophen | 44 | $1,710 | $39 |
| Diclofenac | 11 | $693 | $63 |
| Meloxicam | 39 | $241 | $6 |
| Tramadol | 23 | $123 | $5 |
2016: 5 drugs
| Hydrocodone-Acetaminophen | 141 | $4,120 | $29 |
| Oxycodone-Acetaminophen | 44 | $2,741 | $62 |
| Acetaminophen-Codeine | 14 | $270 | $19 |
| Tramadol | 32 | $195 | $6 |
| Meloxicam | 26 | $141 | $5 |
2015: 8 drugs
| Hydrocodone-Acetaminophen | 152 | $5,453 | $36 |
| Janumet | 27 | $3,534 | $131 |
| Oxycodone-Acetaminophen | 36 | $3,332 | $93 |
| Diclofenac | 26 | $654 | $25 |
| Tramadol | 32 | $295 | $9 |
| Ibuprofen | 13 | $166 | $13 |
| Meloxicam | 22 | $139 | $6 |
| Sulfamethoxazole-Trimethoprim | 16 | $99 | $6 |
2014: 12 drugs
| Hydrocodone-Acetaminophen | 293 | $6,828 | $23 |
| Janumet | 43 | $3,368 | $78 |
| Oxycodone-Acetaminophen | 38 | $3,236 | $85 |
| Voltaren | 15 | $2,528 | $169 |
| Losartan | 12 | $547 | $46 |
| Diclofenac | 16 | $419 | $26 |
| Acetaminophen-Codeine | 14 | $179 | $13 |
| Meloxicam | 20 | $168 | $8 |
| Warfarin | 26 | $113 | $4 |
| Lactulose | 11 | $107 | $10 |
| Simvastatin | 12 | $100 | $8 |
| Sulfamethoxazole-Trimethoprim | 12 | $82 | $7 |
2013: 9 drugs
| Voltaren | 47 | $7,366 | $157 |
| Hydrocodone-Acetaminophen | 350 | $6,246 | $18 |
| Oxycodone Hcl-Acetaminophen | 18 | $815 | $45 |
| Tramadol | 33 | $396 | $12 |
| Meloxicam | 21 | $280 | $13 |
| Acetaminophen-Codeine | 14 | $227 | $16 |
| Warfarin | 26 | $132 | $5 |
| Naproxen | 12 | $86 | $7 |
| Amoxicillin | 13 | $81 | $6 |
Money from drug and device companies
$89 in 2023
| 2023 | 1 | 1 | None | $89 |
| 2022 | 3 | 8 | None | $542 |
| 2021 | 2 | 5 | None | $145 |
| 2019 | 2 | 5 | None | $139 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Zimmer Biomet Holdings | Persona | $89 | 1 payment
|
See the published payment
| Zimmer Biomet Holdings | Meals · 2023-01-17 | Persona | $89 |
See earlier years (2022, 2021, 2019)
2022: $542
| Zimmer Biomet Holdings | Persona | $382 | 6 payments
|
| Smith+Nephew | Bioinductive Implant With Arthroscopic Delivery System - Medium | $144 | 1 payment
|
| Nevro | Omnia | $15 | 1 payment
|
2021: $145
| Zimmer Biomet Holdings | Arcos | $88 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $57 | 3 payments
|
2019: $139
| Zimmer Biomet Holdings | Taperloc | $120 | 4 payments
|
| Stryker | Variax | $19 | 1 payment
|
Checkups this office reported
1 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 71.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for Merit-based Incentive Payment System (MIPS)As Medicare defines this measure | 0% | None |
Professional record
- NPI
- 1427061092
- Licence
- CA G82064California G82064: Current · expires 2027-06-30
- Trained
- University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb), 1991 · 35 years ago
- Group
- Orion Orthopaedic Trauma Inc · County of San Joaquin · Samaritan Pacific Health Services Inc
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 4870629
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- Po Box 576158, Modesto, CA, 95357
- NPI first listed
- 2006-08-14
- NPI last updated
- 2026-01-02
- NPI record certified
- 2026-01-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 825 Nw Highway 101 Ste A, Lincoln City, OR, 97367 · 930 Sw Abbey St Ste A, Newport, OR, 97365
This office lists an electronic records connection.